Latanoprost Related Compound E CAS 41639-83-2

Latanoprost Related Compound E CAS 41639-83-2

Identification

CAS Number

41639-83-2

Name

Latanoprost Related Compound E(Latanoprost (free acid))

Synonyms

(5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid [ACD/IUPAC Name]
(5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptensäure [German] [ACD/IUPAC Name]
(5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoic acid
(5Z,9α,11α,15R)-9,11,15-Trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oic acid
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid
41639-83-2 [RN]
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, (5Z)- [ACD/Index Name]
Acide (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phénylpentyl]cyclopentyl}-5-hepténoïque [French] [ACD/IUPAC Name]
Latanoprost (free acid)
Latanoprost acid
latanoprost free acid
Latanoprost Related Compound E
MFCD08056084
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid
(5Z,9α,11α,15R)-9,11,15-Trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oic acid
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenyl-pentyl]cyclopentyl]hept-5-enoic acid
[41639-83-2]
1224443-47-3 [RN]
13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2α
7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pentyl)-cyclopentyl]-hept-5-enoic acid
9?,11?,15R-trihydroxy-17-phenyl-18,19,20-trinor-prost-5Z-en-1-oic acid
9α,11α,15R-trihydroxy-17-phenyl-18,19,20-trinor-prost-5Z-en-1-oic acid
9α,11α,15R-trihydroxy-17-phenyl-18,19,20-trinor-prost-5Z-en-1-oic acid
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63925
latanoprost (free acid form)
Latanoprost Acid-d4
Latanoprost impurity H
Latanoprostacid
latanoprost-free acid
latanoprost-free acid|PHXA85
Latanprost free acid
Latanprost free acid
Latanprost?free?acid
NCGC00165820-01
PHXA85

SMILES

c1ccc(cc1)CC[C@@H](CC[C@H]2[C@@H](C[C@@H]([C@@H]2C/C=C\CCCC(=O)O)O)O)O

StdInChI

InChI=1S/C23H34O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,18-22,24-26H,2,7,10-16H2,(H,27,28)/b6-1-/t18-,19+,20+,21-,22+/m0/s1

StdInChIKey

HNPFPERDNWXAGS-NFVOFSAMSA-N

Molecular Formula

C23H34O5

Molecular Weight

390.513

Properties

Appearance

Light yellow to brown liquid

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Latanoprost Related Compound E CAS 41639-83-2

Identification Methods

HNMR, HPLC

Purity

95% min

Water

≤1.0%

Loss on Drying

≤1.0%

Total Impurities

≤3.0%

Shelf Life

2 years

Storage

Store at 2°C ~ 8°C for long time, in container tightly sealed; Protect from light and moisture.

Known Application

Latanoprostacid is an analog of prostaglandin (PG) F2α. It can be used to reduce intraocular pressure and is often used in the treatment of glaucoma.

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).